Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Viper Partners, formerly referred to as Viper Equity Partners, is a private healthcare-focused investment banking and M&A advisory firm serving physician practice owners and healthcare services businesses rather than a drug-development biotech company. The firm advises on practice sales, recapitalizations, growth strategy, capital raising, financing, and related strategic transactions, with particular emphasis on dentistry, aesthetics, dermatology, plastic surgery, med spas, cardiology, vascular surgery, optometry, ENT, and rheumatology. Its business model centers on connecting medical practices with private-equity-backed dental and medical support organizations, family offices, lenders, and other buyers. Viper also offers adjacent advisory services in loans, real estate, and transaction preparation for medical practices. For a biotech analyst, the key point is that this is a healthcare services advisory/investment banking company, not a therapeutics developer with a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Viper Partners.